Robert Nesse, MD, the senior director of Policy and Payment Reform at Mayo Clinic, discussed the impact of healthcare consolidation for consumers, whether or not they are aware of it, and how the government will respond to this consolidation.
Robert Nesse, MD, the senior director of Policy and Payment Reform at Mayo Clinic, discussed the impact of healthcare consolidation for consumers, whether or not they are aware of it, and how the government will respond to this consolidation.
Transcript (modified)
What are consumer reactions to consolidation in healthcare? Do they know it’s happening? Do they know why it’s happening?
I don’t belive they’re thinking about the megastructures of what’s going on in healthcare, but it can impact them very immediately, and that would be if their provider has changed, their employment status or somebody else’s has changed, the insurance model can change, and then that patient can no longer go to that provider or, at least, not until they change their insurance. Then it’s immediate. And the patient can’t put that into some larger context so that hits immediately.
Another thing I think can happen is as these models change very quickly, benefits models change, too. People that are used to one set of benefits can end up in trouble unless they read carefully the fine print, if you will, of the insurance model going forward—even the bold print of the insurance model going forward—in order to make the transition.
In 2015 there were a number of large healthcare mergers announced. Do you think we’ll start to see the government cracking down on these mergers?
It depends on how they turn out. So remember that while we might have all heard about 50 insurance company mergers, 500 medical groups merged and were acquired last year, in 2015. This is being done not just for market power, there are forces that really the government would like in terms of coordinated care, population health models, more advanced analytics, meaningful use of electronic medical records—all of those require groups to get bigger.
So you really can’t say we want a model in which people require or need integrated care to be successful both in the provider viewpoint and a patient viewpoint, and then say we can’t support the structure that allows that. So I don’t think they’ll be stopped, I think they’ll be heavily regulated and that’s probably appropriate.
Bridging the Gaps: New Strategies for Preventing Cardiovascular Disease
July 31st 2025During the Addressing Cardiovascular Risk and Intervening Early webinar, experts discussed innovative strategies for cardiovascular disease prevention, emphasizing risk assessment, lifestyle changes, and collaborative care to improve patient outcomes.
Read More
Trends in Insulin Out-of-Pocket Costs and Use Disparities, 2008-2021
July 31st 2025Given trends in cost and use, insulin out-of-pocket cost reduction policies would be more efficient if they targeted members in high-deductible health plans with savings options and low-income patients.
Read More
The Legal Architecture of Psychedelic Therapy: Risks, Responsibilities, and Reimbursement Realities
July 30th 2025Key legal, ethical, and compliance considerations for managed care professionals navigating the evolving landscape of psychedelic-assisted therapy include regulatory risks, data privacy challenges, reimbursement limitations, and the need for culturally informed care models.
Read More